Supriya Lifescience Ltd. (SUPRIYA)

Volume: 6,297Avg Vol 1W: 2,25,524Avg Vol 1M: 5,82,28452W Range:₹545.5₹1,085

NSE BSE www.supriyalifescience.com

₹914.35▼ 3.44%

Key Ratios

Updated 1h ago

Market Cap—

Current Price₹914.35

Previous Close₹946.9

High / Low (52w)₹1,085 / ₹545.5

Volume6,297

Avg Vol (1W)2,25,524

Avg Vol (1M)5,82,284

Stock P/E31.42

Book Value₹148.79

Dividend Yield—

ROE—

ROA—

Revenue (TTM)₹828 Cr

Revenue Growth—

Profit Margin—

Total Debt—

Shares Outstanding—

Face Value₹2

EPS (TTM)₹9.22

P/B6.42

Debt / Equity—

50 DMA₹836.99

200 DMA₹698.64

Day change-3.44%

Price Chart

₹914.35▲ 21.91% · 1Y

2025-10-20

2026-06-16

20-day avg volume: 3.8L shares

Pros

Revenue grew 1172129307% YoY.
Net profit is growing year over year.

Quarterly Results

Metric	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024	Jun 2024	Mar 2024	Dec 2023	Sept 2023	Jun 2023	Mar 2023	Dec 2022	Sept 2022	Jun 2022	Mar 2022	Dec 2021	Sept 2021	Jun 2021	Mar 2021	Dec 2020
Revenue	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
EBITDA	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Net Profit	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
EPS	9.22	6.17	6.27	4.32	6.29	5.82	5.71	5.54	4.59	3.7	2.97	3.54	4.75	1.18	2.1	3.14	5.74	4.93	7.96	0.96	6.63	2.14

Profit & Loss (Annual)

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue	₹828 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
EBITDA	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Net Profit	₹209 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
EPS	—	23.35	14.8	11.16	18.86	16.89	10.02

Balance Sheet

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Total Assets	₹1,357 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Total Liabilities	₹159 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Equity	₹1,198 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Total Debt	₹5 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr

Cash Flow

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Operating	₹186 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Investing	₹-176 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Financing	₹-10 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Free Cash Flow	₹34 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr

Shareholding

Promoter 68.3% Institutions 10.86% Public 20.84%

About Supriya Lifescience Ltd.

Pharmaceuticals · Pharmaceuticals - Indian - Bulk Drugs & Formln

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, antihypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search